DBV Technologies
Tracked across 6 events · 37 articles · First seen Apr 02, 2026 · Last active Jul 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: DBV Technologies announced the screening of the first participant in its THRIVE Phase 2 clinical study for the VIASKIN Peanut Patch, which could significantly advance its product pipeline and market position if successful.
Jun 02, 2026 · 6 articles
Regulatory
Impact: DBV Technologies is the company issuing the regulatory filing regarding its total number of shares and voting rights.
Apr 02, 2026 · 7 articles
Business
Impact: DBV Technologies will participate in the Goldman Sachs 47th Annual Global Healthcare Conference, providing an opportunity to present its developments and potentially attract investor interest.
Jun 05, 2026 · 6 articles
Business
Impact: DBV Technologies is the issuer of the liquidity contract report, which is a routine disclosure. The report shows increased share holdings in the liquidity account but no significant change in market perception.
Jul 06, 2026 · 6 articles
100
DBV Technologies filed regulatory information France — Autorité des marchés financiersDBV Technologies files share count
ERGEN INTELLIGENCE
Track DBV Technologies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard